Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137)

K Shimura, E Kodama, Y Sakagami… - Journal of …, 2008 - Am Soc Microbiol
Integrase (IN), an essential enzyme of human immunodeficiency virus (HIV), is an attractive
antiretroviral drug target. The antiviral activity and resistance profile in vitro of a novel IN …

HIV‐1 integrase inhibitors: 2005–2006 update

R Dayam, R Gundla, LQ Al‐Mawsawi… - Medicinal Research …, 2008 - Wiley Online Library
Abstract HIV‐1 integrase (IN) catalyzes the integration of proviral DNA into the host genome,
an essential step for viral replication. Inhibition of IN catalytic activity provides an attractive …

Mechanisms and inhibition of HIV integration

C Marchand, AA Johnson, E Semenova… - Drug Discovery Today …, 2006 - Elsevier
HIV integrase (IN) is required for viral replication and a rationale target for antiretroviral
therapies. Integrase inhibitors are potentially complementary to current treatments. This …

In-Silicodocking of HIV-1 integrase inhibitors reveals a novel drug type acting on an enzyme/DNA reaction intermediate

A Savarino - Retrovirology, 2007 - Springer
Abstract Background HIV-1 integrase (IN) is an emerging drug target, as IN strand transfer
inhibitors (INSTIs) are proving potent antiretroviral agents in clinical trials. One credible …

The catalytic mechanism of HIV-1 integrase for DNA 3′-end processing established by QM/MM calculations

AJM Ribeiro, MJ Ramos… - Journal of the American …, 2012 - ACS Publications
The development of HIV-1 integrase (INT) inhibitors has been hampered by incomplete
structural and mechanistic information. Despite the efforts made to overcome these …

Induced‐fit docking approach provides insight into the binding mode and mechanism of action of HIV‐1 integrase inhibitors

ML Barreca, N Iraci, L De Luca… - ChemMedChem …, 2009 - Wiley Online Library
A three‐dimensional model of a complex between HIV‐1 integrase (IN), viral DNA, and
metal ions that we recently built was used as a target for a docking method (induced‐fit …

A dynamic model of HIV integrase inhibition and drug resistance

AL Perryman, S Forli, GM Morris, C Burt… - Journal of molecular …, 2010 - Elsevier
Human immunodeficiency virus type 1 (HIV-1) integrase is one of three virally encoded
enzymes essential for replication and, therefore, a rational choice as a drug target for the …

HIV-1 integrase strand-transfer inhibitors: design, synthesis and molecular modeling investigation

L De Luca, S De Grazia, S Ferro, R Gitto… - European journal of …, 2011 - Elsevier
This study is focused on a new series of benzylindole derivatives with various substituents at
the benzene-fused ring, suggested by our 3D pharmacophore model developed for HIV-1 …

Subunit-specific protein footprinting reveals significant structural rearrangements and a role for N-terminal Lys-14 of HIV-1 Integrase during viral DNA binding

Z Zhao, CJ McKee, JJ Kessl, WL Santos… - Journal of Biological …, 2008 - ASBMB
To identify functional contacts between HIV-1 integrase (IN) and its viral DNA substrate, we
devised a new experimental strategy combining the following two methodologies. First …

Posttranslational acetylation of the human immunodeficiency virus type 1 integrase carboxyl-terminal domain is dispensable for viral replication

M Topper, Y Luo, M Zhadina, K Mohammed… - Journal of …, 2007 - Am Soc Microbiol
ABSTRACT A recent report sought to demonstrate that acetylation of specific lysines within
integrase (IN) by the histone acetyltransferase (HAT) p300 regulates human …